Core Laboratories Company Insiders
| CLB Stock | USD 16.95 0.92 5.74% |
Core Laboratories employs about 3.3 K people. The company is managed by 20 executives with a total tenure of roughly 84 years, averaging almost 4.0 years of service per executive, having 165.0 employees per reported executive. Analysis of Core Laboratories' management performance can provide insight into the company performance.
| Lawrence Bruno Chairman Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer |
| Kevin Daniels President Vice President, Chief Accounting Officer |
Core Laboratories Management Team Effectiveness
The company has Return on Asset of 0.0497 % which means that on every $100 spent on assets, it made $0.0497 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1226 %, implying that it generated $0.1226 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.The majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Core Laboratories in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Core Laboratories, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Core Laboratories Workforce Comparison
Core Laboratories NV is rated third in number of employees category among its peers. The total workforce of Energy industry is currently estimated at about 23,766. Core Laboratories retains roughly 3,300 in number of employees claiming about 14% of equities under Energy industry.
The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income. Core Laboratories Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Core Laboratories insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sow Teo over a month ago Disposition of 864 shares by Sow Teo of Core Laboratories subject to Rule 16b-3 | ||
Anastasio Curt over three months ago Acquisition by Anastasio Curt of 8069 shares of Core Laboratories subject to Rule 16b-3 | ||
Sow Teo over three months ago Disposition of 108 shares by Sow Teo of Core Laboratories at 10.53 subject to Rule 16b-3 | ||
Martinovich Robert F over six months ago Insider Trading | ||
Kwaku Temeng over six months ago Disposition of 5485 shares by Kwaku Temeng of Core Laboratories subject to Rule 16b-3 | ||
Michael Straughen over six months ago Disposition of 4634 shares by Michael Straughen of Core Laboratories at 14.98 subject to Rule 16b-3 | ||
Michael Straughen over six months ago Disposition of 9317 shares by Michael Straughen of Core Laboratories subject to Rule 16b-3 | ||
Christopher Hill over six months ago Acquisition by Christopher Hill of 23607 shares of Core Laboratories subject to Rule 16b-3 |
Core Laboratories Notable Stakeholders
A Core Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Core Laboratories often face trade-offs trying to please all of them. Core Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Core Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Lawrence Bruno | Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer | Profile | |
| Kevin Daniels | Vice President, Chief Accounting Officer | Profile | |
| Christopher Hill | Chief Financial Officer, Senior Vice President | Profile | |
| Mark Elvig | Senior Vice President, Secretary, and General Counsel | Profile | |
| Billy Anthony | President Tools | Profile | |
| Margaret Kempen | Independent Member of the Board of Supervisory Directors | Profile | |
| Mark JD | Secretary VP | Profile | |
| Sow Teo | Treasurer VP | Profile | |
| Gwendolyn MBA | Senior Relations | Profile | |
| J Dumas | Vice President Business Development | Profile | |
| Martha Carnes | Presiding Non-Executive Lead Independent Member of the Supervisory Board | Profile | |
| Monique Eeuwijk | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Jacobus Schouten | Managing Director | Profile | |
| Kwaku Temeng | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Gregory Barnett | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Mark Tattoli | Senior Vice President General Counsel, Secretary | Profile | |
| Harvey Klingensmith | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Michael Straughen | Non-Executive Independent Member of the Supervisory Board | Profile | |
| Gwendolyn Gresham | Senior Vice President Corporate Development and Investor Relations | Profile | |
| Leslie Linklater | Organization, People | Profile |
About Core Laboratories Management Performance
The success or failure of an entity such as Core Laboratories often depends on how effective the management is. Core Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Core management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Core management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management manipulating its earnings.
Core Laboratories Workforce Analysis
Traditionally, organizations such as Core Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Core Laboratories within its industry.Core Laboratories Manpower Efficiency
Return on Core Laboratories Manpower
| Revenue Per Employee | 158.7K | |
| Revenue Per Executive | 26.2M | |
| Net Income Per Employee | 9.7K | |
| Net Income Per Executive | 1.6M | |
| Working Capital Per Employee | 39.1K | |
| Working Capital Per Executive | 6.5M |
Complementary Tools for Core Stock analysis
When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |